Addenda Capital’s Pfizer PFE Stock Holding History

Addenda Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7M	Hold	290,800	–	–	0.19%	97
2026 Q1	$8.17M	Hold	290,800	–	–	0.23%	90
2025 Q4	$7.24M	Sell	290,800 -31,579	-10%	-$796K	0.21%	93
2025 Q3	$8.21M	Buy	322,379 +68,176	+27%	+$1.68M	0.24%	85
2025 Q2	$6.16M	Sell	254,203 -1,510	-0.6%	-$35.2K	0.22%	103
2025 Q1	$6.48M	Buy	255,713 +57,025	+29%	+$1.49M	0.24%	96
2024 Q4	$5.27M	Sell	198,688 -561	-0.3%	-$15.2K	0.19%	112
2024 Q3	$5.77M	Buy	199,249 +10	+0%	+$292	0.21%	112
2024 Q2	$5.57M	Sell	199,239 -33	-0%	-$909	0.22%	107
2024 Q1	$5.53M	Buy	199,272 +947	+0.5%	+$26.3K	0.21%	110
2023 Q4	$5.71M	Buy	198,325 +45,380	+30%	+$1.37M	0.22%	100
2023 Q3	$5.07M	Sell	152,945 -145	-0.1%	-$5.13K	0.22%	103
2023 Q2	$5.62M	Buy	153,090 +33,182	+28%	+$1.29M	0.24%	97
2023 Q1	$4.89M	Sell	119,908 -923	-0.8%	-$39.9K	0.2%	113
2022 Q4	$6.19M	Sell	120,831 -1,568	-1%	-$75.2K	0.27%	81
2022 Q3	$5.36M	Buy	+122,399	New	+$5.95M	0.24%	83

Other funds holding PFE

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

ORIO

Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Kepler Cheuvreux Nyon $1.75B AUM 37.37% 1-Year Est. Return

WAM

Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

Addenda Capital's PFE Position: Q2 2026 in Review

Addenda Capital held its Pfizer (PFE) position steady in Q2 2026 at 290,800 shares worth $7M. The position accounts for 0.19% of the portfolio, ranked #97.

Addenda Capital first reported a position in PFE in Q3 2022 and has held it in 16 quarters since. The position peaked at $8.21M in Q3 2025. 491 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Addenda Capital held 290,800 shares of Pfizer worth $7M as of Q2 2026.
Addenda Capital left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.19% of Addenda Capital's portfolio in Q2 2026, its #97 holding.
Addenda Capital first reported a position in Pfizer in Q3 2022 and has held it in 16 quarters since.
Addenda Capital's Pfizer position peaked at $8.21M in Q3 2025.
491 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Addenda Capital's 13F filing for Q2 2026, filed 14 Jul 2026.